Focus and Mindfulness News: June 2026

Three stories from the past fortnight that matter if you use apps, timers or medication to keep your attention where you want it. One research team says the blocker apps themselves may be part of the problem, Apple has rebuilt Screen Time, and the ADHD medication supply picture in the US has worsened again.

Distraction blockers can backfire for neurodivergent users, UBC research finds

Researchers at the University of British Columbia studied 27 neurodivergent students and found that rigid distraction-blocking apps often clash with how brains with ADHD, autism or anxiety actually work. Fixed intervals like the 25-minute Pomodoro block can cut off hard-won hyperfocus, and many participants deliberately switched their blockers off to watch familiar, calming content, a self-regulation strategy the authors call digital stimming. Several said the apps left them feeling more ashamed about their productivity, not less. The work was presented at the CHI 2026 conference and covered by Phys.org on 4 June. If you have bounced off strict blockers before, this is evidence the fault may be the tool’s design, not your discipline; our guide to focus apps for ADHD weights flexibility for exactly this reason, and we cover when fixed intervals fail in why the Pomodoro Technique stops working.

Apple redesigns Screen Time in iOS 27

At WWDC on 8 June, Apple announced a redesigned Screen Time for iOS 27 alongside two new parental controls, Ask to Browse and Time Allowances, plus a new AI health coach built on Apple Intelligence. The full rundown is in MacRumors’ WWDC 2026 recap. The buyer angle: if you currently pay for a third-party blocker mainly to limit your own phone use, or a child’s, it is worth waiting to see what the rebuilt Screen Time does for free when iOS 27 ships in the autumn before renewing a subscription.

US ADHD medication shortage widens, with some recovery dates as far out as January 2027

The US FDA is reporting that nine manufacturers, including Teva, Sandoz and Aurobindo, have limited or no availability of some doses of Adderall, Ritalin and their generics, with methylphenidate products such as Concerta among those affected. Estimated recovery dates range from days to January 2027 depending on the manufacturer, and patients are being advised to check several pharmacies and ask prescribers about alternatives, as reported on 4 June. Supply has been bumpy on both sides of the Atlantic for over two years now, so if your focus routine leans entirely on medication, it is sensible to have non-drug supports in place too; our guide to stopping your mind wandering covers techniques that cost nothing and need no prescription.